EUREKARE
eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.
EUREKARE
Industry:
Biotechnology Finance Financial Services
Founded:
2020-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
60 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-04 | DNA Script | eureKARE investment in Series C - DNA Script | 200 M USD |
| 2021-11-25 | Gynov | eureKARE investment in Corporate Round - Gynov | N/A |
More informations about "eureKARE"
eureKARE
EureKARE seeks disruptive synthetic biology solutions to tackle environmental and sustainability challenges In collaboration with the European project SYNBEE, which strives to enhance โฆSee details»
About - eureKARE
EureKARE news & blog; Ventures news. Join Us; X. ... Alexandre Mouradian is Chairman of the Mouradian Foundation, a charitable organization set up to promote a deeper understanding of โฆSee details»
eureKARE - Crunchbase Investor Profile & Investments
EureKARE is focused on investing in synthetic biology biotechnology companies and creating new ventures. Paris, Ile-de-France, France; 11-50; Venture Capital Early Stage Venture, Seed eurekare.eu ; 6,981; Highlights. Investments 4. โฆSee details»
eureKARE - Investing in SynBio Innovation - LinkedIn
EureKARE is an investment company focused on financing and developing synthetic biology innovation across Europe. Driven by the belief that synthetic biology holds the key to many of โฆSee details»
People - eureKARE
Our People Backed by a Board of renowned scientific experts, our leadership team and staff have exceptional experience in science and business. Our Team Alexandre Mouradian Founder, โฆSee details»
eureKARE announces participation of the European Innovation โฆ
Sep 20, 2021 Serge Pampfer, eureKARE CSO, commented: โIntegral to the eureKAWARDS is the high level of support and guidance the winning project will receive. Having a person of Dr. โฆSee details»
eureKARE - Investments, Portfolio & Company Exits - Crunchbase
EureKARE is focused on investing in synthetic biology biotechnology companies and creating new ventures. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Which โฆSee details»
eureKARE launches with $60 million to build and finance next โฆ
May 18, 2021 eureKARE is guided by influential founder, Alexandre Mouradian, accompanied by a highly skilled team and an international Scientific Advisory Board of renowned experts. Paris, โฆSee details»
eureKARE welcomes Dirac Biosciences as first company into its ...
Feb 1, 2023 According to World Health Organization and World Cancer Research Fund International reports, in 2020, 18.1 million people were diagnosed with cancer and nearly 10 โฆSee details»
EureKARE raises $60M to create EU synbio and microbiome startups
May 17, 2021 EureKARE, which was founded and backed by Spinoza Foundation chairman Alexandre Mouradian, has persuaded high-net-worth investors and family offices to back its โฆSee details»
eureKARE - EU-Startups
EureKARE is a visionary investment firm dedicated to advancing synthetic biology innovation throughout Europe. With a firm belief in the transformative potential of synthetic biology to โฆSee details»
Vision & Mission | eureKARE
Discover eureKARE. Investing in Europe's Best As an investment company, we are the first to focus on supporting the best of Europe-UK-Israel's synthetic biologists and microbiome โฆSee details»
eureKING
Michael Kloss Co-Founder & CEO of eureKING โIn just a few months we have seen tremendous support garnered for the eureKING project. We met our key objective of raising โฌ150 million โฆSee details»
eureKARE launches innovation-driven start-up studio in
Nov 15, 2022 eureKARE launches innovation-driven start-up studio in Monaco to apply synthetic biology in tackling critical environmental challenges. Luxembourg, Belgium, and Paris, France โฆSee details»
eureKARE supports eureKING in EUR 150 million listing of the first ...
Pooling together eureKAREโs expertise with that of key European industry leaders to create the first European healthcare SPAC dedicated to biomanufacturing, eureKING, is the next step in ...See details»
eureKARE supports eureKING in EUR 150 million listing of
Dec 5, 2022 Consilium Strategic Communications โ Media Relations Amber Fennell, Sukaina Virji, Genevieve Wilson [email protected]. eureKING [email protected]. โฆSee details»
Studios | eureKARE
Scientists know how to use synthetic biology to do amazing things! We know how to catalyze their innovations into successful businesses with access to funding, the right resources at the right โฆSee details»
Eureka (organisation) - Wikipedia
Eureka (often abbreviated as E!, or ฮฃ!) is an intergovernmental organisation for research and development funding and coordination. Eureka is an open platform for international โฆSee details»
eureKARE - Funding, Financials, Valuation & Investors - Crunchbase
EureKARE is focused on investing in synthetic biology biotechnology companies and creating new ventures. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much โฆSee details»
eureKARE co-founds EonBio to revolutionize drug discovery with ...
Feb 22, 2023 eureKARE announces EonBio as the second company to be supported by its Belgium biomedical start-up studio. EonBio is developing pioneering platform technology to โฆSee details»